Drug discovery, HTS
Issue 16 of “Cell Notes,” a serial
publication of !%Promega Corp.%!, focuses on drug discovery and high-throughput screening,
emphasizing the use of in vitro assays to understand in vivo biology. The 32-page
document includes articles on the MultiTox-Fluor multiplex cytotoxicity assay, and
on in vitro compound profiling in 384- and 1536-well plates using bioluminescent
assay systems. It discusses multiplexed viability, cytotoxicity and apoptosis
assays for cell-based screening, and the DPPIV-Glo luminescent protease assay, which
detects Gly-Pro cleaving activity in serum. Sections also cover timing apoptosis
assays and the use of luciferase reporter assays to screen for G-protein-coupled
receptor modulators. A kinase assay product flowchart is included.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024